Post

New research · Rheumatology
Rheumatology (Oxford, England) · 1d
Cohort studyRheumatology (Oxford, England) · 2026

Characterizing arthritis subtypes in lupus: prevalence, clinical features, and role of type I interferon signatures.

Pankti Mehta, Fadi Kharouf, Virginia Carrizo-Abarza … Zahi Touma
Read paper
RheumatologyCohort study

Female sex is associated with higher odds of Jaccoud's arthropathy in lupus patients.

Characterizing arthritis subtypes in lupus: prevalence, clinical features, and role of type I interferon signatures.

Pankti Mehta et al. · Rheumatology (Oxford, England) · 2026
Background

Arthritis is a common manifestation of systemic lupus erythematosus (SLE).

Purpose

Arthritis is a common manifestation of systemic lupus erythematosus (SLE).

Methods

In this observational cohort study at the University of Toronto Lupus Clinic (July 1970-August 2024), arthritis was defined clinically as non-deforming arthritis (NDA), Jaccoud's arthropathy (JA), and arthritis with clinically irreducible deformities (CIDA).

n = 2264 patients
Results

female patients had over twice the odds of Jaccoud's arthropathy (a deforming joint condition)

OR 1.05 (95% CI 1.03 to 1.08)
null = 11.031.08
CI excludes the null - significant
More results

Among 2264 patients, 1248 (55.1%) had arthritis: 908 (72.6%) had NDA, 239 (19.2%) JA, and 101 (8.1%) CIDA.

In patients with available IFN scores (n = 475), CIDA was associated with a low IFN signature in unadjusted analysis, whereas both JA and NDA had a high IFN signature.

“
Conclusion · 1 of 2

Distinct clinical and serologic patterns differentiate JA and CIDA, suggesting unique underlying mechanisms of deforming arthritis in SLE.

Conclusion · 2 of 2

Both NDA and JA exhibited a high IFN signature, while CIDA showed a higher joint burden, lower disease activity, and lower IFN signature relative to NDA.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case Report
creatinine at 6.28 mg/dL
high level of a waste product, indicating severe kidney damage
Study
80% (4/5)
Four out of five patients with refractory systemic lupus erythematosus achieved remission.
Study
AUC = 0.847
Good accuracy separating lupus patients from healthy people (higher AUC = better)
Cohort Study
2.8-fold
Current glucocorticoid dose contributes 2.8-fold more to all neuropsychiatric damage risk.
Cohort Study
HR 2.76 (95% CI: 1.25-6.10)
malnutrition is associated with a higher rate of death in people with systemic sclerosis
Guideline
102 recommendations
guidance for assessing, diagnosing, monitoring, and treating lupus
Cohort Study
0.633
arthritis patients taking JAK inhibitor drugs were less likely to develop new dry eye
Cohort Study
80% vs. 30%
placental blood-flow (vascular malperfusion) damage was far more common in these growth-restricted pregnancies